psiCLIP reveals dynamic RNA binding by DEAH-box helicases before and after exon ligation by Lisa M. Strittmatter et al.
psiCLIP reveals dynamic RNA binding by
DEAH-box helicases before and after exon
ligation
Author Lisa M. Strittmatter, Charlotte Capitanchik,
Andrew J. Newman, Martina Hallegger, Christine
M. Norman, Sebastian M. Fica, Chris Oubridge,














Creative Commons Attribution 4.0 International(https://creativecommons.org/licenses/by/4.0/)
ARTICLE
psiCLIP reveals dynamic RNA binding by
DEAH-box helicases before and after exon ligation
Lisa M. Strittmatter 1,6, Charlotte Capitanchik2,6, Andrew J. Newman1, Martina Hallegger2,3,
Christine M. Norman1, Sebastian M. Fica 1,7, Chris Oubridge1, Nicholas M. Luscombe 2,4,5,7,
Jernej Ule 2,3,7✉ & Kiyoshi Nagai 1
RNA helicases remodel the spliceosome to enable pre-mRNA splicing, but their binding and
mechanism of action remain poorly understood. To define helicase-RNA contacts in specific
spliceosomal states, we develop purified spliceosome iCLIP (psiCLIP), which reveals dynamic
helicase-RNA contacts during splicing catalysis. The helicase Prp16 binds along the entire
available single-stranded RNA region between the branchpoint and 3′-splice site, while Prp22
binds diffusely downstream of the branchpoint before exon ligation, but then switches to
more narrow binding in the downstream exon after exon ligation, arguing against a
mechanism of processive translocation. Depletion of the exon-ligation factor Prp18 destabi-
lizes Prp22 binding to the pre-mRNA, suggesting that proofreading by Prp22 may sense the
stability of the spliceosome during exon ligation. Thus, psiCLIP complements structural
studies by providing key insights into the binding and proofreading activity of spliceosomal
RNA helicases.
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Splicing is an essential step in pre-mRNA processing ineukaryotes, during which non-coding introns are removedand coding exons are ligated. Splicing is catalysed by a large,
dynamic molecular machine called the spliceosome, which
comprises about a hundred proteins in yeast. During the first
splicing step—branching—the spliceosome catalyses attack by the
branch point adenosine (brA) at the 5′-splice site (5′-SS), pro-
ducing a lariat-intermediate structure1. During the second step of
splicing—exon ligation—the cleaved 5′-SS attacks the 3′-splice
site (3′-SS) to ligate the exons and form the mature RNA
(mRNA). To faithfully remove introns, the spliceosome must
accurately recognize the 5′-SS, the brA, and the 3′-SS (Fig. 1A).
Use of the wrong splice sites could ultimately lead to errors in
protein translation and erroneous splicing has been linked to
cancer in humans, leading to the development of therapeutics
designed to modulate splicing2. Eight ATP-dependent helicases—
comprising three DEAD-box helicases (Sub2, Prp5, and Prp28),
four DEAH-box helicases (Prp2, Prp16, Prp22, and Prp43), and a
Ski2-like helicase (Brr2)—ensure splicing fidelity by actively
promoting correct spliceosome assembly and splice site usage3.
All eight helicases are essential in yeast and conserved in
humans4,5.
The DEAD-box helicases Sub2, Prp5, and Prp28 are involved
in early assembly of the spliceosome on introns, promoting
correct splice site recognition5. The Ski2-like helicase Brr2 is
involved in spliceosome activation prior to the first catalytic step
of splicing. The four DEAH-box helicases Prp2, Prp16, Prp22,
and Prp43 remodel the spliceosome through the first (branching)
and second (exon ligation) catalytic steps, and coordinate spli-
ceosome disassembly once the reaction has completed5. In vitro
experiments and structural studies of spliceosomal DEAH-box
helicases showed that they translocate on RNA in the 3′ to 5′
direction to unwind duplexes6,7. Prp16 repositions the substrate
after the branching reaction by removing the branch helix,
formed between the branch point sequence and U2 snRNA, from
the active site of the C-complex spliceosome8–10. Following this
remodelling event, Prp16 dissociates from the C complex and
causes dissociation of the branching factors that stabilize the
branch helix11. Prp16 action generates binding sites for the exon-
ligation factors Slu7 and Prp18 (refs. 10,12,13), resulting in for-
mation of the C* complex, which is competent for exon ligation.
In the C* complex, Prp16 is replaced by Prp22, which proofreads
exon ligation14. Together with the exon-ligation factors Slu7 and
Prp18, Prp22 promotes exon ligation for most pre-mRNA sub-
strates, acting in an ATP-independent manner15. Exon ligation
results in the formation of the spliceosomal P complex that
retains both the excised intron and the mature mRNA, which is
held by spliceosomal proteins and the U5 snRNA11. The mature
mRNA is then released from the spliceosome through the ATP-
dependent activity of Prp22 (refs. 15–17), which also results in the
release of the exon-ligation factors Prp18 and Slu7. Prp22 was
shown to unwind duplex RNA in vitro in an NTP-dependent
manner6,17. After exon ligation, Prp22 crosslinks to the second
exon and was proposed to release the mRNA by translocating
along the second exon in a 3′ to 5′ direction, thus disrupting the
U5 snRNA–mRNA duplex18. Nonetheless, it remained unclear
whether Prp22 translocates directly through the duplex or acts at
a distance.
Despite advances in structural and compositional analysis of
the spliceosome, much is still unknown about helicase-mediated
transitions between spliceosome intermediates11,19. Although
previous research indicates the stages at which helicases are
required, it is not known exactly where on the snRNA and/or pre-
mRNA they bind, how they promote conformational changes in
the spliceosome, nor the mechanism by which they ensure spli-
cing fidelity. Both steps of splicing are reversible, offering the
potential to prevent suboptimal pre-mRNA transcripts from
completing splicing20. Indeed, DEAD/H-box helicases were pro-
posed to promote the backwards reaction for suboptimal splice
sites that engage the spliceosome active site3,21. Two helicase-
mediated proofreading mechanisms were suggested to increase
splicing fidelity. The kinetic model posits that the ATPase activity
of DEAH-box helicases acts as a timer. ATP hydrolysis promotes
either the productive pathway towards exon ligation, for optimal
splice sites, or the discard pathway, for suboptimal splice sites,
depending on the rate of catalysis, which is inferred to be faster
than ATP hydrolysis for optimal substrates3. In the discard
pathway, spliceosomes assembled on suboptimal splice sites are
dissociated by the ATPase Prp43, whose activity safeguards
against the accumulation of splicing errors22. The thermo-
dynamic model proposes that splicing fidelity is enhanced
through modulating the stability of competing spliceosome con-
formations, with suboptimal substrates being rejected because
they promote conformations that compete with catalysis3. Indeed,
DEAH-box helicases were proposed to shift the equilibrium
between different catalytic conformations of the spliceosome23.
Although these two models are not mutually exclusive, their
relative role in proofreading is unknown.
Most helicases bind to the spliceosome only transiently, mak-
ing them difficult to study. Electron cryo-microscopy (cryo-EM)
structures have shown helicases to be at the spliceosome per-
iphery, where they are detected at much lower local resolutions
than other components due to their flexibility. Given their per-
ipheral location in these structures, it remains unclear by what
mechanisms helicases promote remodelling of the RNA-based
catalytic core of the spliceosome.
Additional insights have been gained by site-specific cross-
linking of helicases to pre-mRNA substrates in splicing extracts
upon incorporation of single photo-reactive residues into the
RNA18,24,25. However, the identified binding positions were
limited to the nucleotides chosen for site-specific modification
and were not linked to a specific conformation of the spliceo-
some. Single-molecule fluorescence resonance energy transfer
(smFRET) studies have advanced our understanding of the
mechanism of DEAH-box helicases, suggesting they remodel the
spliceosome active site from a distance9. However, this approach
does not provide precise positional information about
RNA–protein contacts and is technically cumbersome, as the
positioning of FRET probes must be carefully calibrated for each
substrate. Perhaps for this reason, most studies focused on one
specific pre-mRNA transcript, making it difficult to distinguish
transcript-specific effects from general principles.
Transcriptome-wide studies, such as spliceosome iCLIP using
an antibody against the small nuclear ribonucleoprotein-
associated protein B (SmB)26, profiling using Prp19-TAP affi-
nity purification27, and affinity purification of post-catalytic
spliceosomes after mRNA release28, have uncovered new posi-
tional principles for assembly of specific spliceosomal complexes
on pre-mRNAs. However, the contribution of individual splicing
factors is difficult to discern in such profiles. In addition, iCLIP of
individual splicing factors has revealed their position-dependent
capacity to control alternative splicing decisions in mammals29,
but has not led to direct insights into step-specific mechanisms
for the core spliceosome. A key issue with these methods is that
spliceosomes are not stalled at a specific step, therefore the
resulting profiles represent an ensemble of spliceosomal snap-
shots across many splicing steps, with a likely bias towards those
that are rate limiting. This prevents us from assigning specific
binding sites to individual steps. To understand the molecular
mechanisms that underlie splicing fidelity and splice site choice, a
method is needed that is capable of identifying RNA contacts
formed at defined steps of splicing. Such a method would be
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particularly useful in resolving the principles that guide the
binding of spliceosomal helicases to RNA substrates, in identi-
fying potential transcript-specific effects, and for understanding
how the ATPase activities of helicases are linked to their RNA-
binding behaviour and thereby to their proofreading activities.
Here, we present purified spliceosome iCLIP (psiCLIP), a
method to determine the complete range of contacts between
specific splicing substrates and helicases in native spliceosomal
complexes stalled at specific stages of the splicing cycle. UV
crosslinking of an enriched complex makes it possible to capture
the weak and transient binding of DEAH-box helicases. We used
a system of in vitro-assembled spliceosomes in budding yeast
(Saccharomyces cerevisiae), which allows targeted isolation of
helicases at defined points in the splicing pathway and enables
functional characterization of helicases using specific mutants.
We used psiCLIP to analyse two DEAH-box helicases, Prp16 and
Fig. 1 The psiCLIP method reveals the complete RNA-binding profile of an RBP in a specific spliceosomal complex. A Spliceosomes are assembled from
yeast cell extract on an in vitro transcribed pre-mRNA and stalled through different strategies that block the transition towards later stages. Spliceosomes
are depicted in schematics, where U2 snRNP is coloured in yellow, U5 snRNP in blue, and U6 snRNP in orange. The RNA-binding protein of interest is fused
to a C-terminal FLAG tag. After purification of the stalled spliceosome population, spliceosomes are irradiated with a defined UV dose at 254 nm, and
denatured to release the target protein from the complex and allow FLAG capture of the RNA–protein complex. For spliceosomes stalled at steps
containing lariat structures, an additional debranching step was introduced. Controlled RNase I digestion fragments the RNA into suitable pieces for
Illumina NGS. The 5′ end is radio-labelled, while a DNA adapter is attached to the 3′ end, carrying a sequence for primer annealing for reverse transcription.
Finally, the crosslinked RNA–protein complexes are resolved on SDS–PAGE and extracted for RNA library preparation. See “Methods” for details.
B Autoradiographs of RNA after the psiCLIP procedure following capture of Prp16 with either TALON beads for His-tag proteins (left) or anti-FLAG beads
for 3× FLAG tag proteins (right). Signal that arises from Prp16 crosslinked to RNA is expected to be larger than the size of Prp16 at 122 kDa. C anti-FLAG
western blot detecting Prp16-3× FLAG shows that denaturing conditions are required to capture the tagged protein. Purified spliceosomal complex C
containing endogenous Prp16-3× FLAG was captured using anti-FLAG beads after either treatment with 6M urea (right) or under native conditions (left).
In B and C, a representative autoradiograph for wild-type Prp16 is shown; a similar result was obtained with Prp16-G378A.
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Prp22, which act before and after exon ligation, respectively (C,
C*, and P complexes), in the context of multiple pre-mRNA
transcripts. The high sensitivity and resolution of our psiCLIP
data provide insights into helicase dynamics and lay the foun-
dation for future mechanistic studies to dissect helicase functions
in the spliceosome.
Results
Optimized psiCLIP detects RNA binding with positional
specificity. In addition to conventional iCLIP, which uses
crosslinked cells or tissues as starting material30, iCLIP has also
been adapted to study the binding of purified U2AF2 to pre-
mRNAs in vitro31. Here we establish psiCLIP, which adapts
iCLIP for in vitro studies of spliceosomes stalled at defined
stages of the splicing cycle. Native spliceosomes from yeast cell
extracts are assembled in vitro on a defined pre-mRNA sub-
strate and stalled, using substrate modifications or dominant-
negative, recombinant helicases. Enriched step-specific spli-
ceosomes are then purified in a similar way to those used for
structural analysis32 (Fig. 1A), using affinity tags on the specific
pre-mRNA substrate (Supplementary Fig. 1A). As in conven-
tional iCLIP, spliceosomes are irradiated with 254 nm ultra-
violet light to crosslink proteins to the pre-mRNA substrate and
snRNAs. Next, the RNA-binding protein (RBP) of interest is
purified under stringent, denaturing conditions, along with any
crosslinked RNA, followed by cDNA library preparation and
high-throughput sequencing. The computationally processed
sequencing reads provide a profile of RBP–RNA contacts that
occur within the spliceosome enriched for a specific state (see
Methods).
In this study, we used psiCLIP primarily to investigate the
binding profiles of the DEAH-box helicases Prp16 and Prp22 that
act in the spliceosomal C, C*, and P complexes (Fig. 1A).
Therefore, we optimized purification, crosslinking, and RNA
fragmentation for these helicases. Purification using a 3× FLAG
tag was more specific than His-tag purification via TALON beads,
which has been a common choice for crosslinking and
immunoprecipitation33, therefore, we proceeded with 3× FLAG
for all experiments in this study (Fig. 1B). We found that
stringent 6M urea denaturing conditions were required to
capture 3× FLAG-tagged Prp16 bound to a range of RNA
fragment sizes (Fig. 1C). To optimize crosslinking and RNA
fragmentation, we titrated UV and RNase I doses in parallel
(Supplementary Fig. 1B), which showed that the signal was
saturated at a UV dose of 312 × 100 µJ/cm2. We chose the UV
dose so as to give efficient crosslinking, while minimizing the
potential for multiple proximal protein–RNA crosslinks, which
could bias reverse transcription truncations to the 3′ end of the
binding sites. We also titrated the amount of RNase for treatment
of purified spliceosomes so as to minimize the biases that can
result from RNA sequence and structure preferences of the
RNase34,35.
To demonstrate the positional specificity of psiCLIP, we first
assayed binding of the integral protein SmB, which is known to
bind the Sm site in U1, U2, U4, and U5 snRNAs, and is thus
present in spliceosomes at all stages of splicing. The Sm binding
sites have been characterized by genetic studies, which identified a
U-rich consensus sequence as essential for binding36, while the
Sm proteins have been modelled in crystal and cryo-EM
structures37–40. However, the exact nucleotide-binding positions
of the yeast Sm proteins, including their unstructured tail regions,
are unknown for most snRNPs, providing an initial test of our
method.
Spliceosomes were assembled on a substrate with a 3′-SS
mutation from the canonical 3′-UAG| to 3′-UAC| (where | marks
the splice site), which impairs exon ligation. A mixture of pre-
catalytic and catalytic (complex C) spliceosomes were purified by
glycerol gradient and subsequent substrate affinity purification
using MS2 stem–loops on the pre-mRNA substrate. In agree-
ment with a previous study26, psiCLIP performed under
stringent 6 M urea denaturing conditions identified SmB cross-
links primarily on snRNAs, with little signal on the pre-mRNA
substrate (Fig. 2A and Supplementary Fig. 2A). We observed
crosslinks within, and adjacent to, the expected Sm sites, with
little signal in the negative controls (no UV/tagged protein;
Fig. 2B, C and Supplementary Fig. 2B–G). The three-dimensional
structure for the pre-catalytic spliceosomal complex pre-B40
shows that the SmB protein is in close spatial proximity to the
U1 snRNA nucleotides detected using psiCLIP (Fig. 2D). The 5′
end of U1 snRNA extends into the direction of the SmB protein,
thus explaining why psiCLIP detected crosslinks mainly at the
beginning of the Sm site motif. In addition, the crosslinks
upstream of the Sm site identified by psiCLIP (G535 and A536)
interact with the long tail of the SmB protein in the cryo-EM
structure. Only part of this SmB tail could be modelled as an
alpha-helix into the U1 snRNP in the cryo-EM structure of the
yeast pre-B complex, due to its high flexibility3,6. The psiCLIP
data suggest that SmB has a similar configuration in the other
snRNPs (Supplementary Fig. 2B–G). The SmB example shows
that psiCLIP detects RNA–RBP interactions with high positional
specificity and can also provide information on more transient
interactions between flexible protein regions and RNA, which are
challenging to detect by structural methods.
psiCLIP reveals broad binding of Prp16 downstream of brA.
Next, we set out to study the RNA contacts made by spliceosomal
helicases. The DEAH-box helicase Prp16 is essential for the
transition from complex C, the complex after branching, to
complex C*, which catalyses exon ligation13. Prp16 binds tran-
siently to the spliceosome to reposition the splicing substrate,
removing the brA from the active site, creating space that will
later allow the 3′-SS to dock in the active site10,41. This Prp16-
dependent spliceosome remodelling dissociates branching factors
Cwc25 and Yju2, and promotes stable binding of the exon-
ligation factors Slu7 and Prp18 (refs. 9,10,12,13,42,43).
To further optimize psiCLIP, we introduced a debranching step
for spliceosomes bound to the lariat RNA structure produced
after branching, in order to reduce cDNA truncations at branch
points, which could otherwise be erroneously interpreted as
protein–RNA crosslinks26,28 (Supplementary Fig. 3). Despite
debranching, we still observed some cDNA truncations at the
brA, which likely result from truncation at partially digested
three-way lariat junctions (Supplementary Fig. 3A). Therefore, we
removed reads mapping to a five nucleotide region around the
brA (−2 to +2 around brA) to avoid confounding the analysis.
Moreover, we established a way to visualize data across multiple
experiments on a single plot for comparative purposes. The
psiCLIP data provide nucleotide-resolution data on crosslinking
that can be visualized with histograms, with the size of each bar
corresponding to the number of crosslink events at each
nucleotide (Fig. 3A). While nucleotide-resolution histograms
convey precise positional information, as seen in the case of SmB
data (Fig. 2), they cannot be used to present data across multiple
experimental conditions on a single plot since overlapping bars
would not be visible. Therefore, we present the data from helicase
psiCLIP experiments as Gaussian smoothed curves with a
window size of ten nucleotides, which reflects well the cross-
linking trajectory (Fig. 3B), and is in agreement with the nine
nucleotides of RNA bound to the two RecA domains in structures
of DEAH-box helicases7.
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We performed Prp16 psiCLIP using the purified C-complex
spliceosome, which was stalled and enriched using three different
approaches: mutation of the 3′-SS from the canonical 3′-UAG| to
3′-UAC| (where | marks the splice site), addition of recombinant,
ATPase-deficient Prp16-G378A mutant44, or a combination of 3′-
SS and Prp16 mutations. To assess substrate-specific effects, we
compared UBC4 and ACT1—two pre-mRNAs that have been
used extensively in previous spliceosome functional and struc-
tural studies. Under similar conditions that were used to pull
down Prp16 after UV crosslinking, Prp16 binds the lariat
intermediate but not the pre-mRNA, demonstrating that our
method captures reads derived from spliceosomes after branching
(Supplementary Fig. 4A).
psiCLIP of Prp16 shows crosslinks predominantly on the pre-
mRNA substrate, with little signal on snRNAs (Fig. 3C). The
snRNAs that are not present in C complex, such as U1 and
U4 snRNA, are under-represented compared with U2 and
U5 snRNA, which are part of C complex (Fig. 3D). Our three
stalling methods were expected to enrich for the same
spliceosomal state—the C complex stalled right after branching.
Indeed, we found that Prp16 makes similar RNA contacts
regardless of the stalling method, demonstrating the high
reproducibility of the psiCLIP method (Supplementary Figs. 3E,
F and 4C, E). Nonetheless, we found that poorer crosslinking
efficiency for Prp16, compared to Prp22, for example, resulted in
increased stochastic variation in the crosslinking profiles between
replicates (Supplementary Fig. 4B–G).
On both splicing substrates, the binding pattern of Prp16 is
widely spread, producing prominent crosslinks up to 40
nucleotides downstream of the brA and extending well beyond
the predicted 9 nucleotides for the occluded site of a DEAD/H-
box helicase7. On ACT1 Prp16 shows a prominent peak ~30
nucleotides downstream of the brA, whereas on UBC4 the main
peak occurs 20 nucleotides downstream of the brA, though
binding spans the entire region between the brA and the second
exon for both substrates (Fig. 3E, F—sum of all replicates, and
Supplementary Fig. 4C, E—three replicates shown separately).
Although the position of the main crosslinking peak is
significantly different between the two splicing substrates
(p < 0.001, alpha= 0.05, Student’s unpaired two sided t test,
Supplementary Fig. 4H, I), comparisons between substrates need
to be interpreted with caution, as crosslinking efficiency may be
affected by the underlying RNA sequence. Our findings include
positions previously identified using photo-reactive
nucleotides9,25 and confirm inferences from the C-complex
cryo-EM structure, in which at least 18 nucleotides of RNA were
predicted to span the distance between the brA and the RNA
entry site of Prp16. This prediction was drawn from the six
Fig. 2 Validation of the positional specificity of psiCLIP with SmB. A Proportion of cDNAs mapping to substrate and snRNAs for one SmB psiCLIP
experiment on the short UBC4 substrate. B Crosslinking to U1 snRNA. Crosslink events (−1 position of cDNA start) are represented as a histogram and
box plot aligned to the indicated snRNA. On the histogram, the y-axis indicates the proportion of cDNAs out of all cDNAs mapped to snRNAs and pre-
mRNA substrate. The box plot represents crosslink positions from one sample along the transcript, weighted by normalized cDNA count. The line across
the box represents the median; the lower and upper bounds correspond to the first and third quartiles. The whiskers end at the largest and smallest value
no further than 1.5 times the inter-quartile range. Outliers outside of this range are plotted as dots. The Sm site is highlighted in blue throughout. The bar
chart represents the proportion of cDNAs in samples, normalized to the UV condition, which is shown as 100%. No tag: UV-irradiated untagged SmB, no
UV: SmB-3× FLAG without UV irradiation, and UV: UV-irradiated SmB-3× FLAG. C Zoom in to show crosslinking specifically at the Sm sequence element
on U1 snRNA, which is highlighted with a blue background. The U1 snRNA region highlighted in purple is shown in D mapped onto the cryo-EM structure.
D Structure of the U1 snRNP Sm ring in the spliceosomal complex pre-B (ref. 40; PDB: 5ZWN) with the SmB protein in salmon and the nucleotides of
U1 snRNA in gold, with those showing the highest psiCLIP signal in purple or with a purple outline, corresponding to the purple boxes in C.
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nucleotides closest to the brA, which could be modelled into
ordered density, with the additional 12 added based on the
approximate length that would be needed to reach the RNA entry
site of Prp16 (ref. 8; Fig. 3G). Importantly, Prp16 binding did not
appear strictly constrained by the 3′-SS, as binding could be
detected in the second exon for UBC4. Overall psiCLIP provides
comprehensive positional information for Prp16 binding, show-
ing an extensive binding profile in C complex, downstream of
the brA.
Prp16 binding depends on the brA to 3′-SS distance. To test the
constraints on Prp16 binding, we designed transcripts based on
ACT1 with increasing lengths between the brA and 3′-SS. Ran-
domized 20 and 40 nucleotide sequences with the same GC
content as the ACT1 intron were inserted after the brA, creating
transcripts that spliced with similar efficiency to the original
transcript in a wild-type Prp16 background (Fig. 4A–C). psiCLIP
was performed with C-complex spliceosomes assembled on these
substrates and stalled using the ATPase-deficient Prp16 mutant
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(Prp16-G378A). As the distance between brA and 3′-SS was
increased, the binding region of Prp16 expanded to fill the full
intronic region between the brA and 3′-SS (Fig. 4E–G). In all
cases, a clear drop of signal was observed at the intron–exon
boundary (Supplementary Fig. 5A–C), even though the normal-
ized crosslinking signal generally decreases on the extended
transcripts (Supplementary Fig. 5E). We observed crosslinking
~30 nucleotides upstream of the brA, but this was disregarded as
it was inconsistent between replicates and it was also detected in
the control samples (Fig. 4G, H). Thus, our results indicate that
Prp16 binds downstream of the brA on the entire length of
accessible single-stranded RNA, and does not strictly discriminate
between introns and exons.
Prp16-mediated remodelling of C complex removes the brA
from the active site to allow 3′-SS docking for exon ligation.
Prp16 action thus results in remodelling of the branch helix,
which forms between U2 snRNA and the substrate region
upstream of brA (Fig. 3G). The branch helix may be disrupted
during Prp16 action and such disruption may allow Prp16 to
promote use of alternative 3′-SS9. A long-standing puzzle has
been how Prp16, transiently located at the spliceosomal
periphery, can remodel the branch helix, which is buried within
the spliceosome core. Previous work suggests Prp16 can act
indirectly without translocating through the branch helix8,9. To
investigate whether Prp16 could disrupt RNA helices during
remodelling of the spliceosome, we introduced a 40 nucleotide
stem–loop into the ACT1 intron between the brA and the 3′-SS
(Fig. 4D, H, I and Supplementary Fig. 5D). This substrate was
spliced in a wild-type Prp16 background, indicating that the
Prp16 action is not appreciably hindered by the inserted sequence
(Fig. 4D). We then performed psiCLIP on C complexes
assembled on this substrate and stalled with the Prp16-G378A
mutant. We observed Prp16 crosslinking mainly on the predicted
single-stranded region between the stem–loop and the 3′-SS
(Fig. 4H, I). The 5′ arm of the stem–loop showed very little
crosslinking and the 3′ arm showed reduced crosslinking,
suggesting that the stem–loop sequence indeed formed a
secondary structure that hindered Prp16 binding. Since RBPs
preferentially crosslink to single-strand RNA45, the small amount
of crosslinking observed towards the 3′ end of the 3′ arm (Fig. 4I)
suggests that the Prp16 helicase mutant, which retains residual
ATPase activity, may have partially unwound the stem–loop.
Nonetheless, the impaired Prp16 binding we observe is consistent
with a model in which Prp16 remodels the branch helix without
translocating fully through the brA9. Although future experi-
ments will be necessary to determine whether wild-type Prp16
could fully disrupt such stem–loop sequences, our findings for the
mutant Prp16 helicase demonstrate that psiCLIP can be used to
test hypotheses about the activity of DEAH-box helicases in the
context of intact native spliceosomes, thus providing comple-
mentary functional assays to smFRET and cryo-EM studies.
psiCLIP of Prp22 detects repositioning of the helicase after
exon ligation. During remodelling of C complex to the C*
complex, Prp16 dissociates from its binding site on Prp8, allowing
Prp22 to replace Prp16 on Prp8 and to stabilize the C* complex
for exon ligation10–12 (Figs. 1A, 3G, and 5A). Exon ligation forms
the spliceosomal P complex that still contains both the excised
intron and the mature mRNA. RNA density observed in the
Prp22 helicase core in the cryo-EM structure of the C* complex
was assigned to the second mRNA exon, with ~16 nucleotides
needed to span the distance between the last nucleotide of the first
exon and the centre of the Prp22 RNA-binding pocket10. How-
ever, biochemical experiments suggested Prp22 binds on the
intron close to the 3′-SS before exon ligation24. In the structure of
the P-complex spliceosome Prp22 was positioned between
nucleotides 14–21 on the second exon of the UBC4 transcript12,
consistent with biochemical experiments18. Thus the precise
position of Prp22 on the RNA substrate before and after exon
ligation remained unclear.
We performed Prp22 psiCLIP using multiple splicing sub-
strates after enriching for spliceosomes stalled either before (C*
complex) or after exon ligation (P complex). We enriched for the
C* complex by assembling spliceosomes on UBC4 and ACT1
transcripts, in which the 3′-SS G(−1) ribonucleotide was replaced
with a 2′-deoxynucleotide (dG), which blocks exon ligation46.
psiCLIP was then performed using both the wild-type and the
dominant-negative Prp22-K512A ATPase-deficient mutant.
Again, there was little signal on snRNAs, with under-
representation of U1 and U4 snRNAs, which are absent in C*
complex (Fig. 5C, D). Prp22 binding covered a broad region
downstream of the brA on both UBC4 and ACT1 transcripts.
Crosslinks were detected throughout the intron between the brA
and the 3′-SS, including a site at eight nucleotides before the 3′-
SS, which was previously observed in splicing extracts for a
substrate that could not undergo exon ligation24. Crosslinks were
also detected in the second exon, with a major peak at 10–25
nucleotides downstream of the 3′-SS. The psiCLIP profile for
Prp22 covers similar positions as those shown previously to
crosslink to Prp8 and Prp22 using site-specific crosslinking in
spliceosomes at the C*-complex stage47,48, further validating our
method. Thus Prp22 binds broadly on both the intron and second
exon of the lariat intermediate before exon ligation. Importantly,
both the wild-type and mutant Prp22 show a similar psiCLIP
profile, confirming that RNA binding is ATP-independent, as
suggested previously from cryo-EM studies, where RNA density
was observed bound to an open, ATP-free, conformation of the
helicase10,49 (Fig. 5E, F and Supplementary Fig. 6A).
To determine if exon ligation changes Prp22 binding, we
performed Prp22 psiCLIP in P-complex spliceosomes, which was
enriched by adding recombinant Prp22-K512A dominant-negative
mutant protein to block release of the mRNA. P-complex psiCLIP
reads were enriched for mRNA junctions, with 10–15% of mapped
Fig. 3 Prp16 psiCLIP data show substrate-specific binding in a region downstream of the brA. A, B An example of Prp16 data shown as raw crosslinks
and after Gaussian smoothing using different window sizes. Raw crosslink signal is shown as a grey histogram. C Total number of crosslinks summed
across three replicates for each condition (UV crosslinked, 3× FLAG-tagged samples). Colour denotes the RNA species to which the crosslinks map.
D Enrichment of snRNAs in FLAG-tagged Prp16 vs. untagged samples, represented as log2 fold change. Note that for this analysis, crosslinks were first
normalized to the total number of snRNA crosslinks in each sample. E, F Mapping of Prp16 psiCLIP data onto ACT1 and UBC4 splicing substrates. Three
replicates were summed. The smoothed lines show the truncation events normalized to endogenous yeast RNA, with the control signal subtracted from the
UV signal. Lines were Gaussian smoothed with a window size of ten nucleotides. Positions along the transcript are shown relative to the brA. Crosslinking
signals derived from the three different stalling methods show the same pattern. The main peak that reflects the position of the Prp16 helicase is slightly
further downstream on ACT1 than on UBC4. Note that wild-type Prp16 binding on 3′-AC ACT1 substrate is excluded here due to small library sizes and low
reproducibility (Supplementary Fig. 4F). G Cryo-EM structure of Prp16 in C complex shows the helicase at a distance from the brA (ref. 8; PDB: 5LJ3). Six
nucleotides were built into the density after the brA (brA +6 is the last ordered nucleotide). The predicted path of the intron and second exon is shown as
a dotted line, implying a minimum distance of 18 nucleotides between the brA and the entry site of Prp16.
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reads containing the canonical splice junction, compared with a
maximum of 0.09% junction reads for the C* complex
(Supplementary Fig. 6B). We found sharp binding peaks in the
second exons of both splicing substrates at +10 and +20
nucleotides downstream of the exon–exon junction in UBC4 and
ACT1, respectively, with binding extending as far as +40
nucleotides (Fig. 5G, H and Supplementary Fig. 6A). The binding
region determined by psiCLIP is in perfect agreement with the
binding site implied for UBC4 by the complex P cryo-EM
structure, and contains positions +10, +17, +22, and +35 on the
Fig. 4 Prp16 binds the entire available single-stranded RNA between brA and the 3′-SS in ACT1 extended substrates. A–D All versions of the extended
ACT1 substrate are capable of being spliced. Splicing assays were performed in a Prp16-WT background. Only splicing products containing the second exon
are visible, as the 3′ end of the transcript is fluorescently labelled. Gels are representative of two biological replicates. E–H Mapping of the psiCLIP data
generated using Prp16-G378A mutant protein and various forms of the ACT1 splicing substrate, including artificial extensions between the brA and the 3′-
SS. The splicing substrates are aligned onto the brA, and the distance between the brA and the 3′-SS is highlighted in light blue. The smoothed lines show
the truncation events normalized to endogenous yeast RNA, with the untagged signal subtracted from the tagged signal. Lines were Gaussian smoothed
with a window size of ten nucleotides. Positions along the transcript are shown relative to the brA. The crosslinking signal spreads across the whole length
of the sequence between the brA and 3′-SS. I Zoom in on the region around the brA shows the almost complete loss of crosslinking downstream of brA in
the stem–loop experiment.
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second exon of ACT1, which were previously identified by site-
specific crosslinking18. Importantly, the major psiCLIP peak
observed for Prp22 in complex P on the second exon is also
observed in complex C* (Fig. 5E–H), indicating that Prp22 binds
at similar positions within the second exon both before and after
exon ligation. In contrast, psiCLIP suggests that Prp22 no longer
binds the intron after exon ligation, in the P complex.
psiCLIP of Prp22 is sensitive to the presence of auxiliary
factors. Exon ligation of ACT1 and UBC4 requires the exon-
ligation factors Slu7 and Prp18 (ref. 50). It has been suggested
that Slu7 binds the spliceosome first, followed by Prp18 and then
Prp22, although Slu7 and Prp18 may bind together as a
heterodimer43,50. In the C* and P complexes, Slu7 and Prp18
bind the Prp8 RH domain to stabilize the exon-ligation
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conformation10,12 (Fig. 6A) and a loop from Prp18 binds near
the 3′-SS to stabilize its docking in the active site12. Prp18 was
also suggested to promote Prp22 binding to the spliceosome50,
yet the structures of the C* and P complexes did not identify
direct contacts between Prp18 and Prp22. We therefore sought to
investigate whether Prp18 affects Prp22 binding patterns by
performing psiCLIP upon depletion of Prp18 from splicing
extracts. We also compared wild-type Prp22 and ATPase-
deficient Prp22-K512A to assess how the Prp22 binding pat-
tern depends on its ATPase activity.
As expected, the Prp18-depleted extract accumulates lariat
intermediate with both the wild-type and mutant Prp22,
indicating a defect in exon ligation, which could be rescued by
adding recombinant Prp18 (Supplementary Fig. 7A). Next,
psiCLIP was performed using ACT1 transcripts containing either
the canonical 3′-SS or the suboptimal dG modified 3′-SS (3′-
UAdG), which in the absence of Prp18 would both be expected to
enrich for spliceosomes stalled at the C* stage. Indeed, purified
complexes contained lariat intermediate and thus appeared
stalled after branching (Supplementary Fig. 7B, C). We observed
a striking difference in the substrate binding of wild-type and
mutant Prp22 helicases in Prp18-deficient spliceosomes. Wild-
type Prp22 displayed very little psiCLIP signal in the Prp18-
deficient spliceosomes (Fig. 6B–D and Supplementary Fig. 7D–F),
whereas the ATPase-deficient Prp22 helicase showed similar
binding in the presence or absence of Prp18 (Fig. 6B–D). In
contrast to wild-type Prp22, the ATPase-deficient mutant Prp22-
K512A allows more exon ligation at the canonical splice site, as
indicated by the presence of more spliced mRNA reads in the
psiCLIP samples (Supplementary Fig. 7G). Nonetheless, the
majority of the psiCLIP signal derives from lariat intermediates,
suggesting that the depletion of Prp18 destabilizes binding of
wild-type Prp22 before exon ligation, in agreement with previous
biochemical data50. Overall, our psiCLIP data indicate that ATP
hydrolysis destabilizes Prp22 binding when the optimal composi-
tion of the spliceosome is disrupted.
Discussion
Splicing fidelity is safeguarded by eight ATP-dependent helicases,
but their precise binding sites and dynamic interactions with
snRNAs and pre-mRNAs remain poorly understood. Detailed
knowledge of helicase binding profiles is required to understand
how they promote conformational changes in the spliceosome
and ensure splicing fidelity. We developed psiCLIP to define the
RNA contacts of two of the most elusive DEAH-box helicases:
Prp16 and Prp22. We establish new data normalization and
visualization approaches to present insights from comparative
experiments upon mutation of these helicases or depletion of
auxiliary factors in various defined spliceosomal states. Our study
thus presents a strategy that can complement functional insights
from structural studies by combining biochemical isolation of
defined conformations of large RNA–protein complexes with
high-resolution interactomics (psiCLIP) and bioinformatics.
psiCLIP provided mechanistic insights into helicase activity by
revealing the complete binding profile of the helicases Prp16 and
Prp22 on their native substrates, in defined spliceosome com-
plexes. DEAH-box helicases like Prp16 and Prp22 were generally
proposed to bind away from their targets and hydrolyse ATP to
translocate through RNA structures in the 3′ to 5′ direction51.
However, cryo-EM structures of the C, C*, and P complexes
showed that Prp16 and Prp22 bind at the periphery of the spli-
ceosome at least 15–20 nucleotides away from the RNA structures
that they remodel: the branch helix and the mRNA (or lariat
intermediate), respectively. Thus both Prp16 and Prp22 appeared
unable to remodel these sites by directly translocating through
them. In agreement, we found extensive binding of both Prp16
and Prp22 on the substrate downstream of the sites that they
remodel, supporting a mechanism of action at a distance rather
than processive translocation through the remodelled RNA sites.
Single-molecule FRET studies suggested that Prp16 translo-
cates on the lariat intermediate, while remaining anchored on the
C complex (Fig. 3G), acting as a molecular winch that pulls the
substrate out of the active site and disrupts the branch helix to
allow remodelling9. Our psiCLIP data provides further support
for this winching model. Instead of binding at a fixed distance
from the brA, we found that Prp16 binds over the full available
single-stranded RNA region between the brA and 3′-SS, even
when this distance is extended with unstructured RNA. None-
theless, most of the Prp16 psiCLIP signal occurred within ~45
nucleotides downstream of the brA, which correlates with the
most common distance between brA and 3′-SS for unstructured
yeast introns52. This defined region of accessible RNA is likely
determined by the binding of Prp16 to spliceosomal components,
such as Prp8 (Fig. 3G), as well as by RNA secondary structures
formed between the brA and the 3′-SS. Additional single-
molecule and chase experiments are necessary to determine if
the broad binding we observed reflects movement during trans-
location or other forms of dynamic contacts, such as binding,
release, and re-binding. However, since broad contacts were
detected for both the wild-type helicase and the ATPase mutant,
which is likely impaired in translocation44 (Fig. 3E, F and 4E–G),
we propose that the broad binding we observe reflects, at least in
part, multiple rounds of binding and dissociation by one or more
helicase molecules.
Our Prp16 psiCLIP data shows that Prp16 binding can extend
into unstructured RNA inserted after the branch helix. By contrast,
an ATPase-deficient Prp16 mutant could not appreciably bind into
a structured stem–loop region, suggesting that it cannot disrupt
strong RNA helices, even though the structured stem–loop allowed
splicing, and thus C to C* remodelling. Our data thus provide
support for a mechanism of action at a distance, in which Prp16
winches towards the branch helix but remodels the spliceosomal
active site without translocating through the branch helix.
Fig. 5 Prp22 psiCLIP indicates a shift from broad binding in C* complex to narrow binding in P complex. A, B Cryo-EM structures of C* complex and P
complex show Prp22 helicase in light and dark purple, respectively (refs. 8,12; PDB: 5MQ0; PDB: 6EXN). Differential colouring for Prp22 is used simply for
representation purposes; the helicase binds the same site in both complexes. The dotted line represents a possible path for unbuilt RNA regions. C Total
number of crosslinks summed across two UV crosslinked, FLAG-tagged replicates for each condition. Colour denotes the RNA species to which the
crosslinks map. D Enrichment of snRNAs in FLAG-tagged Prp16 vs. untagged samples, represented as log2 fold change. Note that for this analysis,
crosslinks were first normalized to the total number of snRNA crosslinks in each sample. E–H Mapping of Prp22 psiCLIP data onto ACT1 and UBC4
transcripts. The smoothed lines show the truncation events normalized to endogenous yeast RNA, with the control signal subtracted from the UV signal.
Crosslinks are shown after Gaussian smoothing with a ten nucleotide window. Positions on the substrate are given relative to the 3′-SS. P-complex
crosslinks are shown with the intron mapping reads removed. E Prp22-WT and Prp22-K512A psiCLIP on ACT1 substrate in C* complex. F Prp22-WT and
Prp22-K512A psiCLIP on UBC4 substrate in C* complex. In E and F, the proposed P-complex-like signal, potentially diagnostic of 3′-SS docking, is indicated
with an asterisk (*). G Prp22-K512A psiCLIP on ACT1 substrate in P complex. H Prp22-K512A psiCLIP on UBC4 substrate in P complex.
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Similarly to Prp16, psiCLIP revealed broad binding of Prp22
downstream of the brA before exon ligation, independently of
ATPase activity. The high reproducibility of binding profiles
observed at specific substrate positions in several replicates and
across stalling conditions (Supplementary Fig. 4B–G) likely
represents an average of interactions in defined complexes, rather
than resulting from heterogeneous binding or processive translo-
cation events across multiple complexes. Thus, we interpret the
broad binding as evidence that the helicases can bind at multiple
defined regions along the substrate. In the C* complex, we detected
Prp22 binding on the intron before the 3′-SS and on the second
exon downstream of the 3′-SS. The strong signal observed for the
Fig. 6 Prp18 depletion destabilizes wild-type Prp22 binding on the pre-mRNA substrate, but not the binding of the ATPase-deficient Prp22 mutant.
A Binding of Prp22 in the exon-ligation conformation in C* (ref. 10; PDB: 5MQ0 and P (ref. 12; PDB: 6EXN) complexes is stabilized by Prp18 and Slu7
(middle panel). For comparison, binding of Prp16 is shown in the C complex (left panel). During rejection by Prp22, the spliceosome may revert to a C-like
conformation (Ci, ref. 43; PDB: 7B9V), in which both Prp18 and Prp22 may remain loosely bound (right panel). B Prp22 binding to spliceosomes assembled
on the suboptimal 3′-UAdG substrate in mock-depleted extracts. C psiCLIP of Prp22 in spliceosomes assembled on the 3′-UAdG substrate following
depletion of Prp18 (Prp18Δ). D psiCLIP of Prp22 in spliceosomes assembled on the wild-type ACT1 substrate following depletion of Prp18. Both wild-type
and ATPase mutant Prp22 are shown for all experiments. The proposed P-complex-like signal, potentially diagnostic of 3′-SS docking, is indicated with an
asterisk (*). In all panels, crosslinks are shown normalized to endogenous yeast RNA, with reads from untagged Prp22 subtracted from tagged Prp22 reads,
and after applying Gaussian smoothing with a ten nucleotide window.
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wild-type Prp22 protein, as well as the broad profile seen for the
ATPase-deficient K512A mutant, which is unable to translocate,
suggest multiple rounds of stochastic binding and dissociation,
rather than a single ATP-dependent translocation and dissociation
event. Notably, the psiCLIP-binding profile is maintained upon the
inhibition of Prp22 ATPase activity, consistent with an ATP-
independent role for Prp22 in exon ligation15.
The broad accessibility for Prp22 binding in the intron on the
3′-UAdG substrate indicates that the 3′-SS is not stably docked in
the active site in a significant population of C* spliceosomes
assembled on this substrate. Indeed, the 3′-UAdG substrate does
not produce mRNA and no stably docked 3′-SS was detected in
the cryo-EM structure of the C* complex10. The extended intron
binding profile in the C* complex suggests that in the absence of
a stably docked 3′-SS Prp22 can translocate along the lariat-
intermediate upstream of the 3′-SS, or bind and rebind in this
region, potentially to reject these spliceosomes, thus ensuring that
exon ligation occurs only at the correctly docked 3′-SS. Sup-
porting this idea, recent cryo-EM studies indicate that a popu-
lation of spliceosomes assembled on the 3′-UAdG substrate revert
to the branching conformation, potentially as a result of rejection
of the C* complex by Prp22 (refs. 10,43).
psiCLIP also detected substrate rearrangements resulting from
substrate docking and catalysis. In complex P, Prp22 binding
shifted to a narrower region 10–25 nucleotides downstream of the
3′-SS, and we detected the same major peak in the 3′-exon in both
complex C* and complex P (Fig. 5G, H). This exonic binding
position is likely associated with a stably docked 3′-SS and con-
sequently this 3′-exon peak may be diagnostic for complexes in
the exon-ligation conformation. Given the 3′ to 5′ direction of
helicase movement on RNA, the observed shift in the Prp22-
binding profile from major peaks in the intron in C* to major
peaks in the 3′-exon in P complex is inconsistent with a simple
mechanism of processive 3′ to 5′ translocation during Prp22
action. Instead, we propose that Prp22 may initially engage the
substrate on the 3′-exon before exon ligation. After exon ligation,
Prp22 would thread the substrate from the 3′-exon to release the
mRNA from the spliceosome, potentially through repeated
binding and dissociation (Fig. 7 and Supplementary Fig. 8A).
Before exon ligation, Prp22 may promote, and proofread, 3′-SS
sampling and docking by dynamic engagement with the lariat
intermediate, as evidenced by binding in the intron upstream of
the 3′-SS (Figs. 5E, F and 7). Consistent with this idea, Prp22 was
shown to promote sampling of alternative 3′SS (ref. 9).
The psiCLIP-binding profile may thus reflect the proofreading
activity of Prp22 and could be influenced by factors that stabilize
the P complex. Indeed, we found that Prp22 binding to the
substrate depended on the exon-ligation factor Prp18, which
promotes 3′-SS docking. Prp18 indirectly stabilizes Prp22 binding
by locking Prp8 in the exon-ligation conformation in the C* and
P complexes (Fig. 6A). As expected, the Prp22 ATPase-deficient
K512A mutant remained bound to both the canonical and sub-
optimal 3′-UAdG substrate upon Prp18 depletion, consistent
with the ATPase-deficient mutant being intrinsically less prone to
dissociation, even when the exon-ligation conformation is
destabilized in the absence of Prp18 (Supplementary Fig. 6G and
Fig. 6A). Strikingly, binding by the wild-type Prp22 was sig-
nificantly reduced in the absence of Prp18. In the absence of
Prp18, Prp22 may dissociate from the spliceosome and may not
rebind. Depletion of Prp18 may also indirectly increase the
ATPase activity of Prp22, promoting dissociation and reducing
stable binding to the substrate. Indeed, structural studies have
shown that the absence of Prp18 destabilizes the C* and P con-
formation43, and would likely weaken Prp22 binding onto Prp8,
which may be necessary for stable association with the substrate.
Similar to Prp22’s proofreading activity for correct 3′-SS selec-
tion14, wild-type Prp22 may not bind stably in the absence of
Prp18 and could therefore prevent potentially erroneous exon
ligation by incompletely assembled spliceosomes. Consistent with
this idea, in the presence of Prp22-K512A we detected exon–exon
spanning reads corresponding to mRNA (Suplementary Fig. 7G).
Thus, when Prp22 ATPase activity is compromised splicing can
proceed in the absence of Prp18, suggesting that the ATPase
activity of Prp22 may reject spliceosomes lacking Prp18.
Our data imply that productive Prp22 association with the
substrate is dependent more broadly on the stability of the exon-
ligation conformation (Supplementary Fig. 8). In this proofreading
model, Prp22 monitors the thermodynamic stability of the spli-
ceosome by discriminating against complexes that cannot com-
plete exon ligation before Prp22 action, whether due to a
suboptimal, non-canonical, 3′-SS or a suboptimal spliceosome,
resulting for example from poor binding of auxiliary factors. For
such suboptimal spliceosomes the exon-ligation conformation
would be destabilized. Before exon ligation can occur, Prp22 bound
initially in the 3′-exon may either translocate from this position or
dissociate and rebind upstream of the 3′-SS to reject lariat inter-
mediates that cannot stably reach the exon-ligation conformation
(Fig. 5E, F and Supplementary Fig. 8B). Dissociation of Prp22
would reject these complexes and may cause the spliceosome to
revert from the C* complex to an intermediate C-like conforma-
tion (Ci). This Ci conformation may not allow stable re-binding by
Prp22 (Fig. 6A), thus preventing progress to the P complex and
blocking exon ligation by suboptimal spliceosomes. Indeed, the Ci
conformation, in which Prp18 remains loosely bound, was
Fig. 7 Model for substrate binding by spliceosomal helicases during the catalytic stage of pre-mRNA splicing. After branching, Prp16 binds the lariat
intermediate broadly downstream of the brA, though the main binding peaks are observed between the brA and the 3′-SS. Prp16 dissociates during
remodelling to the C* conformation, in which it is replaced by Prp22 before docking of the 3′-SS. In complex C*, before exon ligation, Prp22 binds the lariat
intermediate broadly on the 3′-exon and the intron. Such broad binding may facilitate 3′-SS docking to allow exon ligation. After exon ligation, in complex P,
Prp22 engages the mRNA in a narrow binding window on the 3′-exon, from which it pulls on the RNA substrate to release the mRNA and dissociates
following mRNA release.
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observed by cryo-EM for spliceosomes assembled on the sub-
optimal 3′-UAdG substrate43. Depletion of Prp18 may further
destabilize the C* and P complexes, and push spliceosomes
towards such a C-like conformation. Thus, psiCLIP complements
the interpretation of structural studies and provides mechanistic
insights into the proofreading activities of spliceosomal ATPases.
Taken together, our study raises new questions about the
activity of Prp22 and Prp16 ATPases and, more generally, pro-
vides valuable information about active and passive helicase
activities. Further biochemical work will be required to fully
elucidate the mechanisms behind the phenomena uncovered by
psiCLIP. While psiCLIP is well suited for comparisons between
conditions, the absolute crosslinking levels in psiCLIP are affected
by the variable crosslinking efficiencies of nucleotides and amino
acids, which can lead to biases at the sequence level, as in all
techniques utilizing UV crosslinking. It is known that uridine is
the most favourable crosslinker, followed by guanosine, cytosine,
and adenosine, respectively53. Thus, comparisons of psiCLIP data
between transcripts and/or proteins should take into account
such sequence-specific biases. Looking to the future, we envision
that psiCLIP can be extended to study helicases and other RBPs
in additional biochemically defined RNP complexes, such as the
RBP–rRNA interactions during ribosome biogenesis. For exam-
ple, time-resolved psiCLIP could be used to track the binding
profile of a helicase in motion during RNP remodelling. Thus,
psiCLIP provides a versatile method to investigate fundamental
mechanisms of RNP dynamics and remodelling.
Methods
Yeast strains. All strains used in this study were derived from BCY123 (MATa,
can1, ade2, trp1, Ura3-52, his3, leu2-3, 112, pep4::his+, prb1::leu2+,bar1::HisG+,
lys2::pGAL1/10-GAL4+; Supplementary Table 1). In brief, sequences coding for
protein tags and the respective resistance cassette were amplified from plasmids
coding for the protein tag and resistance cassette with ~60–90 nucleotides
homology to the end of the target gene and the beginning of its 3′ UTR (Sup-
plementary Tables 1 and 3). The linear PCR product was transformed into BCY123
and the cells were plated on selective media containing either 100 μg/mL ClonNAT,
300 μg/mL hygromycin, or 250 μg/mL G418. Positive clones were verified by
Sanger sequencing and expression of the tagged protein was analysed by western
blot using monoclonal ANTI-FLAG® M2-Peroxidase antibody (Sigma Aldrich)
with 1:3000 dilution, c-Myc antibody (9E10) HRP (Santa Cruz Biotechnology) with
1:1000 dilution, or HA-probe antibody (F-7) HRP (Santa Cruz Biotechnology) with
1:1000 dilution to detect the respective tag. Strains containing several C-terminal
tags underwent the cycle several times.
For recombinant protein expression, plasmids based on pRS424 and pRS426
vectors carrying TRP1 and URA3 markers, respectively, were transformed into
BCY123 and grown on YM4 selective media (Supplementary Table 1). Both Prp16
and Prp22 constructs were encoded on pRS424 under the GAL-GAPDH hybrid
promoter.
Preparation of splicing substrates. In vitro transcriptions were performed from
pUC-based vectors with the desired sequence following the T7 promoter (Sup-
plementary Table 2) and containing a 3× MS2 stem–loop sequence either at the 3′
or 5′ end54. Artificial extensions of the ACT1 substrate were generated using oli-
gonucleotides with a random sequence that maintained the same GC content as
that of the original sequence between brA and 3′-SS. These were cloned into a
restriction site following the brA position (Supplementary Table 3). Single clones
were selected with either a single 20 nucleotide insertion (5′-CGA TTT TAT TTA
TTT GAT CT-3′), a 40 nucleotide tandem insertion (5′-CGA AAA TCA AGA
TAA ATA ATC GAA AAT CAA GAT AAA TAA T-3′), or a 40 nucleotide head-
to-head insertion to generate an RNA stem–loop (5′-CGA TTA TTT ATC TTG
ATT TTC GAA AAT CAA GAT AAA TAA T-3′). Long RNA pieces were gen-
erated by run-off transcription. Some splicing substrates (Supplementary Table 2),
including substrates containing a 2′-deoxynucleotide, were generated by ligation
from a long 5′ piece ending before the 3′-SS and short 3′ oligonucleotides. For the
respective UBC4 substrates, oligonucleotides carrying a 3′-Cy5 fluorophore (pur-
chased from Sigma) were added by ligation (Supplementary Table 2). For ACT1,
after ligation of an oligonucleotide and an RNA piece generated by run-off tran-
scription, 3′ end labelling was performed by enzymatic ligation of pCp-Cy5
(Supplementary Table 2). To generate precise 3′ or 5′ ends for ligation, transcripts
included a hepatitis delta virus or hammerhead ribozyme sequence at the respective
end. To join RNA pieces by splint-mediated ligation, the 5′-ends were first phos-
phorylated with T4 PNK (New England Biolabs). RNAs were annealed to bridge
DNA oligonucleotides complementary to the junction by slowly decreasing the
temperature from 80 to 25 °C before ligation with T4 DNA ligase (Supplementary
Table 3)46. Ligated transcripts were gel purified after each ligation step.
Expression and purification of recombinant Prp16 and Prp22. BCY123 cells were
co-transfected with expression vectors pRS426 and pRS424, the latter coding for the
recombinant protein (Supplementary Table 1). Positive transformants were grown in
24 L YM4 selective media supplemented with 1% raffinose at 30 °C. Protein expression
was induced with 2% final concentration of galactose at OD600 1.0. After 12–16 h
further growth at 30 °C, cells were harvested, resuspended in one volume 2× lysis
buffer (2M NaCl, 100mM Tris-Cl pH 9.0, 2mM imidazole, 20mM β-
mercaptoethanol (β-ME), 0.2% IGEPAL CA-630, 4mM CaCl2, 2 mM magnesium
acetate, and EDTA-free protease inhibitor cocktail (Roche)), and frozen in liquid
nitrogen in droplet form. Cells were disrupted in a 6870 Freezer/Mill (SPEX Sam-
plePrep). After thawing, the pH of the extract was raised to 8.5 by addition of 1M Tris
base. Cell debris were removed by ultracentrifugation at 195,000 × g for 90min. The
supernatant was incubated with 2mL Calmodulin-sepharose beads (home made) for
12–16 h at 4 °C. Beads were washed with 5 × 50mL CAL wash buffer (500mM NaCl,
20mM Tris-Cl pH 8.0, 2mM CaCl2, 1 mM magnesium acetate, 1 mM imidazole, and
10mM β-ME) and the proteins eluted in 10 × 5mL CAL elution buffer (500mM
NaCl, 20mM Tris-Cl pH 8.0, 2mM EGTA, 1mM magnesium acetate, 1 mM imi-
dazole, and 10mM β-ME). Protein-containing fractions were pooled and dialyzed
against Ni-NTA binding buffer (1M NaCl, 20mM Tris-Cl pH 8.5, 5mM imidazole,
and 10mM β-ME) for 4 h at 4 °C. After 14 h binding to 4mL Ni-NTA agarose beads
(Qiagen), the beads were first washed with 15mL Ni-NTA binding buffer and then
with 15mL Ni-NTA wash buffer (1M NaCl, 20mM Tris-Cl pH 8.5, 15mM imida-
zole, and 10mM β-ME). The protein was eluted in about six 4mL fractions with Ni-
NTA elution buffer (1M NaCl, 20mM Tris-Cl pH 8.5, 250mM imidazole, and
10mM β-ME). Helicases were dialyzed against the respective helicase storage buffer
for 4 h at 4 °C and stored at −80 °C until further use (20mM HEPES pH 7.9, 0.2mM
EDTA, 0.5mM DTT, 20% glycerol with 250mM KCl for Prp16 and 300mM KCl for
Prp22).
Expression and purification of recombinant Prp18. The coding sequence for
Prp18 was cloned into pET14. The protein was expressed as N-terminal His6-
thrombin-Prp18 in Escherichia coli BL21 (DE3)RIL cells. The protein was first
purified on Ni-NTA-agarose beads and peak fractions dialyzed against buffer
containing 10 mM potassium phosphate and 50 mM KCl pH 7.4. The protein was
further purified on a hydroxyapatite column, eluted with 0.5–3.0% ammonium
sulfate, and dialyzed into a suitable buffer for splicing reactions (20 mM HEPES pH
7.9, 0.2 mM EDTA, 0.5 mM DTT, 20% glycerol, and 250 mM KCl).
Splicing extract preparation and in vitro splicing. Yeast splicing extract was
prepared using the liquid nitrogen method55. In vitro splicing reactions were
performed with 2.5 nM splicing substrate in 40% splicing extract, 2 mM ATP,
2.5 mM MgCl2, and 60 mM potassium phosphate pH 6.5 (ref. 56). The resulting
RNA species were phenol extracted and analysed on 5% (for ACT1) or 10% (for
UBC4) denaturing polyacrylamide gels. Quantification of gel bands was done using
ImageJ (ref. 57).
Protein depletion from splicing extract. Prp18-3× HA was depleted from splicing
extract by increasing the KCl concentration to 750 mM and incubating twice with
1/10 volume anti-HA magnetic beads at 4 °C for several hours, followed by dialysis
against 20 mM HEPES pH 7.9, 0.2 mM EDTA, 0.5 mM DTT, 20% glycerol, and
200 mM KCl for 16 h. To ensure complete depletion of Prp18 while preventing co-
depletion of Slu7, western blots against Prp18-3× HA and Slu7-9xcmyc were
performed. To rescue the splicing defect caused by Prp18 depletion, rPrp18 was
added to the splicing reaction at a final concentration of 165 ng/mL (ref. 58).
Spliceosome assembly and purification. Complexes were assembled in a 1.5 mL
splicing reaction on the indicated pre-mRNA substrate, which was pre-bound to a
1.25 fold excess of MS2-MBP fusion protein54. For reactions containing recom-
binantly expressed helicase mutants, the splicing extract was firstly incubated with
15 ng/mL final concentration of dominant-negative mutant protein (Prp16-G378A
or Prp22-K512A). Reactions were incubated at 23 °C for 30 min (UBC4 transcripts)
or 60 min (ACT1 transcripts). For C and C* complex purification, the reaction
mixture was adjusted to 2 mM glucose and incubation prolonged for 5 min. For the
C* complex, beads were incubated with 2 mM ATP/2 mM MgCl2 for 30 min at
room temperature before the wash steps10. For P-complex purification, to remove
spliceosomes before the P-complex stage, reactions were incubated with 5 µM of a
DNA oligonucleotide complementary to the 3′-exon for an additional 20 min
(ref. 12; Supplementary Table 3).
For all spliceosome preparations, the reaction mixture was centrifuged through
a 40% glycerol cushion in buffer A (20 mM HEPES, pH 7.9, 75 mM KCl, and
0.25 mM EDTA). The cushion was collected and applied to amylose resin. After 15
h of incubation at 4 °C, the resin was washed three times with 1 mL buffer A and
eluted for 20 min in 200 μL buffer A containing 5% glycerol, 0.01% NP-40, and
12 mM maltose.
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Spliceosome crosslinking, immunoprecipitation, and cDNA library preparation.
For each helicase experiment, at least two replicates were produced from indepen-
dently assembled and purified spliceosomes, although not necessarily from inde-
pendent extract preparations. In addition, control samples containing no tag on the
protein and non-irradiated samples were prepared. Crosslinking and immunopreci-
pitation were adapted from the original iCLIP protocol34 with the following mod-
ifications. The 200 μL spliceosome eluate was irradiated by UV light using a
Stratalinker 2400 at 254 nm. Spliceosomes with the target protein SmB were irradiated
with 312 × 100 μJ/cm2 and spliceosomes with the target protein Prp16 or Prp22 with
312 × 100 μJ/cm2 (assembled on UBC4) or 625 × 100 μJ/cm2 (assembled on ACT1). A
total of 72mg urea was added and dissolved by shaking to gain a 6M solution to
denature the complex. The protein of interest was captured by magnetic anti-FLAG
beads. The beads were incubated in 20% S100, 8mM EDTA, and 40 μL debranching
buffer (20mM HEPES 7.9, 20% glycerol, 100mM KCl, and 0.5 mM DTT) for 15min
to debranch intron lariats59. A total of 0.5–5 units (depending on complex and
splicing transcript) of RNase I was added over 3min at 37 °C for fragmentation.
Dephosphorylation, adapter ligation, radioactive labelling, isolation of the
RNA–protein complex, and cDNA library preparation were performed as in iCLIP.
cDNA libraries were sequenced at the Illumina HiSeq 2500 platform with cycle
lengths between 100 and 250 nucleotides in single-read mode using HiSeq control
software v2.2.68. An overview of all psiCLIP samples with respective adapter and RT
primer sequences is given in Supplementary data 1.
Data processing. A custom psiCLIP software pipeline was developed in Snake-
make60 and is available from github.com/luslab/psiclip. The code is easily
extended to other experimental scenarios and substrates. Reads were demulti-
plexed using iCount demultiplex and trimmed for quality using Trim Galore!
(https://www.bioinformatics.babraham.ac.uk/projects/trim_galore/). Quality of
sequencing data was assessed with FastQC (https://www.bioinformatics.
babraham.ac.uk/projects/fastqc/). Trimmed reads were mapped to a custom
transcriptome index consisting of S. cerevisiae U1, U2, U4, U5, and U6 snRNAs
alongside the pre-mRNA substrate sequence, using STAR aligner61. Key para-
meters were: –alignEndsType EndToEnd to prevent soft-clipping of reads
which would obscure the truncation site, –outFilterMismatchNmax 2 to
allow a maximum of two mismatches and –seedSearchStartLmax 16, which
means the read is split into more seeds resulting in a potentially more sensitive
search given our short reads. Subsequently, Sambamba was used to retrieve reads
mapping only in the forward orientation to the custom transcriptome62, as psi-
CLIP is stranded. Finally, the cDNA start position −1 is taken as the crosslink site
and bed files are generated, using Bedtools and R63. Reads that did not map to the
custom transcriptome index were then mapped to the yeast genome (SacCer3) and
similarly processed to generate crosslinks. We used the proportion of yeast gen-
ome mapping RNA in the library as internal normalization, much like a spike-
in64. Further plotting and analysis is performed in R using dplyr (https://cran.r-
project.org/web/packages/dplyr/index.html), ggplot2 (ref. 65), and smoother
(https://CRAN.R-project.org/package=smoother) packages. Data for Prp22 and
Prp16 are presented as Gaussian smoothed curves with a window size of ten
nucleotides. In the main figures, the sum of all replicates is shown, where available,
with replicates shown separately in the Supplementary Material.
Data availability
psiCLIP data are available to download from ArrayExpress at E-MTAB-8895. Structural
biology data that was used for comparison was taken from the following publicly
available sources: https://doi.org/10.2210/pdb5ZWN/pdb, https://doi.org/10.2210/
pdb5LJ3/pdb, https://doi.org/10.2210/pdb5MQ0/pdb, https://doi.org/10.2210/pdb6EXN/
pdb, and 7B9V. The data supporting the findings of this study are available from the
corresponding author upon reasonable request. Source data are provided with this paper.
Code availability
Scripts for data pre-processing and downstream processing are available from github.
com/luslab/psiclip (ref. 66), https://doi.org/10.5281/zenodo.4439637.
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